Skip to content
Screener

Total debt at other companies

AbbVie logo
AbbVieABBV
$62.36B+1.8%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$62.71M-22.5%
Regenxbio logo
RegenxbioRGNX
$68.95M-11.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$20.54M-13.9%
Opko Health logo
Opko HealthOPK
$49.94M-7.5%
uniQure logo
uniQureQURE
$62.83M-5.8%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$304.5M+381%
Enterprise value$245.74M+672%
P/S25.4×+21.3×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

The source filing: Opus Genetics’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-034084

FAQ

What is Opus Genetics's total debt?
Opus Genetics (IRD) reported total debt of $1.2M in Q1 2026.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about Opus Genetics's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude